神经分子医学 SCIE

期刊简介预计审稿时间： 12周，或约稿

NeuroMolecular Medicine publishes cutting-edge original research articles and critical reviews on the molecular and biochemical basis of neurological disorders. Studies range from genetic analyses of human populations to animal and cell culture models of neurological disorders. Emerging findings concerning the identification of genetic aberrancies and their pathogenic mechanisms at the molecular and cellular levels will be included. Also covered are experimental analyses of molecular cascades involved in the development and adult plasticity of the nervous system, in neurological dysfunction, and in neuronal degeneration and repair. NeuroMolecular Medicine encompasses basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death. The information published in NEMM will provide a window into the future of molecular medicine for the nervous system.

《神经分子医学》发表关于神经系统疾病的分子和生化基础的前沿原创研究文章和评论。研究范围从人类群体的遗传分析到神经系统疾病的动物和细胞培养模型。将包括有关在分子和细胞水平上识别遗传异常及其致病机制的新发现。还涵盖了涉及神经系统发育和成人可塑性、神经功能障碍以及神经元退化和修复的分子级联的实验分析。《神经分子医学》涵盖分子遗传学、信号转导、可塑性和细胞死亡领域的基础研究。NEMM 上发表的信息将为神经系统分子医学的未来提供一个窗口。

《Neuromolecular Medicine》(神经分子医学)编辑部通讯方式为HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。